NDAINTRAVENOUSSOLUTION
Approved
Mar 2017
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
4/8 — Partial
EPHEDRINE SULFATE (ephedrine sulfate) by Dr. Reddy's Laboratories is α- and ß adrenergic receptors and indirectly causes the release of norepinephrine from sympathetic neurons. Approved for allergic rhinitis. First approved in 2017.
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Ephedrine sulfate is a sympathomimetic amine administered intravenously as a solution for allergic rhinitis. It works by directly activating α- and β-adrenergic receptors and indirectly releasing norepinephrine from sympathetic neurons, increasing arterial pressure, cardiac output, and peripheral resistance. The drug addresses nasal congestion and allergic symptoms through dual adrenergic pathway stimulation.
Peak
Product is at peak maturity with moderate competitive pressure (30/100), suggesting stable but not expanding brand team infrastructure.
Mechanism of Action
α- and ß adrenergic receptors and indirectly causes the release of norepinephrine from sympathetic neurons. Pressor effects by direct alpha- and beta-adrenergic receptor activation are mediated by increases in arterial pressures, cardiac output, and peripheral resistance. Indirect adrenergic…
Indications (1)
Clinical Trials (1)
Bioequivalence Study of Desloratadine and Pseudoephedrine Sulfate Extended-release Tablets Under Fasting Conditions
Started Apr 2006
34 enrolled
Healthy
Career Relevance
Zero linked job postings indicate minimal current hiring demand for ephedrine sulfate–specific roles; career opportunities are limited to downstream maintenance activities or portfolio diversification roles. Professionals joining would focus on defending market share rather than driving growth in a mature, competitive indication.
Worked on EPHEDRINE SULFATE at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.